Dr John Mandrola discusses the QCOR cancellation, LVADs, gene therapy for heart failure, statins in the elderly, and hand sanitizers.

John Mandrola reviews congenital heart disease guidelines, sports and long QT, sleep apnea and AF, divorce and MI, and the Dr Oz scandal.

John Mandrola on monitoring new oral anticoagulants; the FDA's approval of Corlanor, review of cangrelor, and warning on diabetes drugs; leadless pacemaker; and electronic health records.

John Mandrola discusses cooling after cardiac arrest, sports-related cardiac arrest, statins in the young, an antidote to factor Xa inhibitors, and CV mortality rates.

John Mandrola reviews a new EAS statement on statins and myalgia, statins and coronary calcium, exercise benefits, a MADIT-CRT substudy, and the maintenance-of-certification debacle.

Removal of leadless pacemakers, APEX trial, the Mediterranean diet, music therapy, and inequalities in TAVI use worldwide are discussed by Dr Mandrola in this week's podcast.

From ACC: rate vs rhythm for postop AF, TAVR in intermediate-risk AS, PCSK9 inhibitors for statin intolerance, HOPE-3, and FIRE and ICE are discussed as well as the approval of a leadless pacemaker.